Intentional overdose with semaglutide is an infrequently reported phenomenon. We present the case of a 39-year-old transgender male-to-female who attempted suicide by an intentional overdose of semaglutide (Ozempic). Her symptoms after the overdose were mild and self-limiting in nature. This finding reflects positively on the safety profile of the frequently prescribed weight-loss and diabetes medication, Ozempic.
Authors
Branch, Matthew R; Amador, Isabella E; Tardif, Irina; Patel, Kruti K; Lewis, Daniel A